Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 233

1.

Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy.

Privitera MD, Brodie MJ, Mattson RH, Chadwick DW, Neto W, Wang S; EPMN 105 Study Group.

Acta Neurol Scand. 2003 Mar;107(3):165-75.

PMID:
12614309
2.

A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial.

Marson AG, Appleton R, Baker GA, Chadwick DW, Doughty J, Eaton B, Gamble C, Jacoby A, Shackley P, Smith DF, Tudur-Smith C, Vanoli A, Williamson PR.

Health Technol Assess. 2007 Oct;11(37):iii-iv, ix-x, 1-134.

3.

Topiramate, carbamazepine, and valproate monotherapy: double-blind comparison in children with newly diagnosed epilepsy.

Wheless JW, Neto W, Wang S; EPMN-105 Study Group.

J Child Neurol. 2004 Feb;19(2):135-41.

PMID:
15072107
4.

Differential cognitive and behavioral effects of topiramate and valproate.

Meador KJ, Loring DW, Hulihan JF, Kamin M, Karim R; CAPSS-027 Study Group.

Neurology. 2003 May 13;60(9):1483-8.

PMID:
12743236
5.

Drug interaction profile of topiramate.

Bourgeois BF.

Epilepsia. 1996;37 Suppl 2:S14-S17. Review.

PMID:
8641241
6.

Conversion from valproic acid onto topiramate in adolescents and adults with epilepsy.

Schreiner A, Stollhoff K, Ossig W, Unkelbach S, Lüer W, Bogdanow M, Schauble B; TOPMAT-EPY-403 investigators.

Acta Neurol Scand. 2009 May;119(5):304-12. doi: 10.1111/j.1600-0404.2008.01130.x.

PMID:
19133865
7.

[Efficacy of carbamazepine, valproate and topiramate in the treatment of medial temporal epilepsy in children].

Boldyreva SR, Ermakov AIu.

Zh Nevrol Psikhiatr Im S S Korsakova. 2010;110(4):41-7. Russian.

PMID:
20517209
8.

Topiramate monotherapy in the treatment of newly or recently diagnosed epilepsy.

Ben-Menachem E, Sander JW, Stefan H, Schwalen S, Schäuble B.

Clin Ther. 2008 Jul;30(7):1180-95. Review.

PMID:
18691980
9.

A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures.

Aldenkamp AP, Baker G, Mulder OG, Chadwick D, Cooper P, Doelman J, Duncan R, Gassmann-Mayer C, de Haan GJ, Hughson C, Hulsman J, Overweg J, Pledger G, Rentmeester TW, Riaz H, Wroe S.

Epilepsia. 2000 Sep;41(9):1167-78.

10.

[Comparative efficacy of carbamazepine, valproic acid and topiramate in symptomatic and cryptogenic frontal lobe epilepsy in children].

Boldyreva SR, Ermakov AIu.

Zh Nevrol Psikhiatr Im S S Korsakova. 2010;110(6):58-65. Russian.

PMID:
20559276
11.

Effectiveness of first antiepileptic drug.

Kwan P, Brodie MJ.

Epilepsia. 2001 Oct;42(10):1255-60.

12.

Comparative Long-Term Effectiveness of a Monotherapy with Five Antiepileptic Drugs for Focal Epilepsy in Adult Patients: A Prospective Cohort Study.

Zeng QY, Fan TT, Zhu P, He RQ, Bao YX, Zheng RY, Xu HQ.

PLoS One. 2015 Jul 6;10(7):e0131566. doi: 10.1371/journal.pone.0131566. eCollection 2015.

13.

[Comparative efficacy of carbamazepine, valproic acid and topiramate in symptomatic and cryptogenic occipital lobe epilepsy in children].

Boldyreva SR, Ermakov AIu.

Zh Nevrol Psikhiatr Im S S Korsakova. 2010;110(5 Pt 1):39-44. Russian.

PMID:
21322824
14.

Conversion from carbamazepine or oxcarbazepine to topiramate in adolescents and adults with epilepsy.

Kowalik A, Rimpau W, Adam H, Kühn F, van Oene J, Schreiner A, Bogdanow M, Schauble B; TOPMAT-EPY-405 investigators.

Acta Neurol Scand. 2008 Mar;117(3):159-66. doi: 10.1111/j.1600-0404.2007.00977.x. Epub 2008 Jan 23.

PMID:
18218062
15.

KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.

Trinka E, Marson AG, Van Paesschen W, Kälviäinen R, Marovac J, Duncan B, Buyle S, Hallström Y, Hon P, Muscas GC, Newton M, Meencke HJ, Smith PE, Pohlmann-Eden B; KOMET Study Group.

J Neurol Neurosurg Psychiatry. 2013 Oct;84(10):1138-47. doi: 10.1136/jnnp-2011-300376. Epub 2012 Aug 29.

PMID:
22933814
16.

A comparative study of the effect of carbamazepine and valproic acid on the pharmacokinetics and metabolic profile of topiramate at steady state in patients with epilepsy.

Mimrod D, Specchio LM, Britzi M, Perucca E, Specchio N, La Neve A, Soback S, Levy RH, Gatti G, Doose DR, Maryanoff BE, Bialer M.

Epilepsia. 2005 Jul;46(7):1046-54.

17.

A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy.

Christe W, Krämer G, Vigonius U, Pohlmann H, Steinhoff BJ, Brodie MJ, Moore A.

Epilepsy Res. 1997 Mar;26(3):451-60.

PMID:
9127726
18.

Randomized dose-controlled study of topiramate as first-line therapy in epilepsy.

Arroyo S, Dodson WE, Privitera MD, Glauser TA, Naritoku DK, Dlugos DJ, Wang S, Schwabe SK, Twyman RE; EPMN-106/INT-28 Investigators.

Acta Neurol Scand. 2005 Oct;112(4):214-22.

PMID:
16146489
19.

Efficacy, tolerability, and safety of rapid initiation of topiramate versus phenytoin in patients with new-onset epilepsy: a randomized double-blind clinical trial.

Ramsay E, Faught E, Krumholz A, Naritoku D, Privitera M, Schwarzman L, Mao L, Wiegand F, Hulihan J; CAPSS-272 Study Group.

Epilepsia. 2010 Oct;51(10):1970-7. doi: 10.1111/j.1528-1167.2010.02670.x.

20.

Comparison of the steady-state pharmacokinetics of topiramate and valproate in patients with epilepsy during monotherapy and concomitant therapy.

Rosenfeld WE, Liao S, Kramer LD, Anderson G, Palmer M, Levy RH, Nayak RK.

Epilepsia. 1997 Mar;38(3):324-33.

Supplemental Content

Support Center